Code of Federal Regulations: Containing a Codification of Documents of General Applicability and Future Effect as of December 31, 1948, with Ancillaries and IndexDivision of the Federal Register, the National Archives, 1998 Special edition of the Federal Register, containing a codification of documents of general applicability and future effect ... with ancillaries. |
No grāmatas satura
1.–5. rezultāts no 100.
26. lappuse
... dissolution values among batches of digoxin tab- lets does not exceed 20 percent . ( 3 ) Before releasing for ... dissolution and either ( a ) that the quantity of digoxin dissolved at one hour is not more than 95 percent of the assayed ...
... dissolution values among batches of digoxin tab- lets does not exceed 20 percent . ( 3 ) Before releasing for ... dissolution and either ( a ) that the quantity of digoxin dissolved at one hour is not more than 95 percent of the assayed ...
31. lappuse
... dissolution medium throughout the test . ( ii ) Standard solutions . Accurately weigh approximately 25 milligrams of The United States Pharmacopeia Dig- oxin Reference Standard , dissolve in a minimum amount of 95 percent ethanol in a ...
... dissolution medium throughout the test . ( ii ) Standard solutions . Accurately weigh approximately 25 milligrams of The United States Pharmacopeia Dig- oxin Reference Standard , dissolve in a minimum amount of 95 percent ethanol in a ...
32. lappuse
... dissolution . Determine the percentage dissolution of digoxin in the test solutions by reading from the standard graph . ( iv ) Digoxin tablets formulated so that the quantity of digoxin dissolved at one hour , when tested by the method ...
... dissolution . Determine the percentage dissolution of digoxin in the test solutions by reading from the standard graph . ( iv ) Digoxin tablets formulated so that the quantity of digoxin dissolved at one hour , when tested by the method ...
202. lappuse
... dissolve the recommended dose far exceeds the volume of fluids present in the stomach ( taken to be 100 milliliters ... dissolve poorly and this poor dissolution may affect absorption . ( 5 ) Such drug products have a high ratio of ...
... dissolve the recommended dose far exceeds the volume of fluids present in the stomach ( taken to be 100 milliliters ... dissolve poorly and this poor dissolution may affect absorption . ( 5 ) Such drug products have a high ratio of ...
303. lappuse
... Dissolve in water the quantities of metacresol , phenol , glycerin , and diso- dium phosphate required to make 10 li- ters of the batch of isophane insulin and dilute to 1,000 milliliters . ( ii ) The insulin solution . From a sam- ple ...
... Dissolve in water the quantities of metacresol , phenol , glycerin , and diso- dium phosphate required to make 10 li- ters of the batch of isophane insulin and dilute to 1,000 milliliters . ( ii ) The insulin solution . From a sam- ple ...
Saturs
279 | |
285 | |
290 | |
299 | |
310 | |
331 | |
339 | |
340 | |
223 | |
236 | |
238 | |
239 | |
240 | |
256 | |
257 | |
262 | |
263 | |
265 | |
270 | |
275 | |
351 | |
483 | |
588 | |
593 | |
696 | |
699 | |
761 | |
826 | |
865 | |
890 | |
911 | |
949 | |
Citi izdevumi - Skatīt visu
Bieži izmantoti vārdi un frāzes
abbre abbreviated application abbreviated new drug acid active ingredient adverse drug experience agency amended antibiotic application or abbreviated bacitracin bioavailability bioequivalence cation Center for Drug certification chapter clinical hold clinical investigation conducted control number copy Cosmetic Act digoxin dosage form dose Drug Administration drug application Drug Evaluation drug prod drug product Drug products containing drug substance Evaluation and Research Federal Food Food and Drug graph gredients hearing hydrochloride identified information requirements ap insulin intended inves investigational new drug labeling manufacturer marketing meet ment milligrams milliliters misbranded neomycin notice oral dosage orphan drug OTC drug product package paragraph percent person plication polymyxin proposed protocol recognized as safe reference listed drug request safe and effective safety section 502 Sodium sponsor statement submission Subpart sulfate tained tigational tion tive treatment treatment IND vestigational viated warning